γ-aminobutyric acid type A receptor and glycine receptor (GABA_A receptor (GABA_AR), Glycine receptor (GlyR))

GABA_A and glycine receptors are structurally and functionally related pentameric ligand-gated chloride channels that mediate the principal forms of fast synaptic inhibition in the brain (GABA_A receptors) and spinal cord/brainstem (glycine receptors)[3][5]. Both are activated by their respective neurotransmitters—γ-aminobutyric acid (GABA) or glycine—causing chloride influx through the pore, membrane hyperpolarization, and neuronal inhibition[3][5]. GABA_A receptors are highly heterogeneous, with multiple subunit combinations generating functional diversity and selective pharmacology; they are targeted by many clinically important drugs (benzodiazepines, barbiturates, Z-drugs, anesthetics)[2][4][6]. Glycine receptors, which can also be activated by GABA and other agonists but are strongly inhibited by strychnine, play a crucial role in motor control and sensory processing, and genetic mutations can lead to disorders such as hyperekplexia[5]. Both receptor types cluster at inhibitory synapses via direct interaction with the scaffolding protein gephyrin, which is essential for synaptic localization and function[1][3]. Dysfunction or dysregulation of these receptors is implicated in several human diseases, particularly epilepsy, anxiety, sleep disorders, spasticity, and some neurodevelopmental disorders[3][4][5].

Other names

GABA(A) receptorGABAARGABA_AGlyR

Positive allosteric modulation (e.g., benzodiazepines, Z-drugs enhance GABA effect on GABA_A receptor); Direct agonism (e.g., muscimol, GABA for GABA_A; glycine for GlyR); Channel opening duration modulation (barbiturates increase Cl^- channel open time); Channel antagonism/blockade (strychnine blocks glycine receptor)